Product NDC: | 0573-2952 |
Proprietary Name: | PRIMATENE |
Non Proprietary Name: | ephedrine hcl, guaifenesin |
Active Ingredient(s): | 12.5; 200 mg/1; mg/1 & nbsp; ephedrine hcl, guaifenesin |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0573-2952 |
Labeler Name: | Pfizer Consumer Healthcare |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | part341 |
Marketing Category: | OTC MONOGRAPH FINAL |
Start Marketing Date: | 20040106 |
Package NDC: | 0573-2952-20 |
Package Description: | 5 BLISTER PACK in 1 CARTON (0573-2952-20) > 12 TABLET in 1 BLISTER PACK |
NDC Code | 0573-2952-20 |
Proprietary Name | PRIMATENE |
Package Description | 5 BLISTER PACK in 1 CARTON (0573-2952-20) > 12 TABLET in 1 BLISTER PACK |
Product NDC | 0573-2952 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | ephedrine hcl, guaifenesin |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20040106 |
Marketing Category Name | OTC MONOGRAPH FINAL |
Labeler Name | Pfizer Consumer Healthcare |
Substance Name | EPHEDRINE HYDROCHLORIDE; GUAIFENESIN |
Strength Number | 12.5; 200 |
Strength Unit | mg/1; mg/1 |
Pharmaceutical Classes |